Cite
HARVARD Citation
Böll, B. et al. (2019). Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial. British journal of haematology. pp. 42-52. [Online].